Cesamet™ (nabilone)

DRUG3 trials

Sponsors

NEMA Research, Inc.

Conditions

Antineoplastic Combined Chemotherapy ProtocolsDiabetic NeuropathiesMultiple SclerosisPeripheral Neuropathy

Phase 4

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy

CompletedNCT00380965

NEMA Research, Inc.Antineoplastic Combined Chemotherapy Protocols, Peripheral Neuropathy

Start: 2006-10-31End: 2007-10-31Target: 23Updated: 2008-02-15

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy

CompletedNCT00380913

NEMA Research, Inc.Diabetic Neuropathies

Start: 2006-09-30End: 2007-10-31Target: 23Updated: 2008-02-15

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis

CompletedNCT00381264

NEMA Research, Inc.Multiple Sclerosis

Start: 2006-09-30End: 2007-10-31Target: 23Updated: 2008-02-15